Raastel Beta 50 Tablet ER
Marketer
Metalis Lifesciences Pvt Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Raastel Beta 50 Tablet ER
Beta-50 ER extended-release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food daily, at the same time, as directed by your physician. Continue treatment as prescribed; discontinuing, even if feeling well, is inadvisable as hypertension is often asymptomatic and could worsen your condition. Lifestyle changes, including regular exercise, weight management, and a balanced diet, are also crucial. Always follow your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium levels, shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness is possible; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, and electrolyte levels may be required. Inform your doctor of any pre-existing liver or kidney conditions, and if you are pregnant or breastfeeding. Always disclose all current medications, particularly those for hypertension or heart problems.
Primary Ingredients of Raastel Beta 50 Tablet ER
No text provided to rephrase.
Uses of Raastel Beta 50 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Raastel Beta 50 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Raastel Beta 50 Extended-Release Tablet should be administered with a meal.
Common Side effects of Raastel Beta 50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Raastel Beta 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Raastel Beta 50 Tablet ER. Ingest the tablet whole; do not chew, crush, or fracture it. Administer this medication with a meal.
How Raastel Beta 50 Tablet ER works:
Raastel Beta 50 Extended-Release tablets contain a blend of telmisartan and metoprolol succinate, both agents used to manage hypertension.
SAFETY ADVICE
AlcoholUNSAFE
Combining Raastel Beta 50 ER tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Raastel Beta 50 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Raastel Beta 50 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Raastel Beta 50 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneySAFE IF PRESCRIBED
Raastel Beta 50 Extended-Release tablets pose no safety concerns for individuals with renal impairment. No dosage modification is necessary for this medication in such patients.
LiverCAUTION
Patients with liver impairment should use Raastel Beta 50 Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Raastel Beta 50 Tablet ER :
Should you forget to take a Raastel Beta 50 Tablet ER, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Raastel Beta 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |




